Literature DB >> 25153502

Menin immunoreactivity in secretory granules of human pancreatic islet cells.

Larisa V Debelenko1, Sunita Agarwal, Qiang Du, Wusheng Yan, Heidi S Erickson, Mones Abu-Asab, Mark A Raffeld, Steven K Libutti, Stephen J Marx, Michael R Emmert-Buck.   

Abstract

The protein product of the Multiple Endocrine Neoplasia Type I (MEN1) gene is thought to be involved in predominantly nuclear functions; however, immunohistochemical (IHC) analysis data on cellular localization are conflicting. To further investigate menin expression, we analyzed human pancreas (an MEN1 target organ) using IHC analyses and 6 antibodies raised against full-length menin or its peptides. In 10 normal pancreas specimens, 2 independently raised antibodies showed unexpected cytoplasmic immunoreactivity in peripheral cells in each islet examined (over 100 total across all 10 patients). The staining exhibited a distinct punctate pattern and subsequent immunoelectron microscopy indicated the target antigen was in secretory granules. Exocrine pancreas and pancreatic stroma were not immunoreactive. In MEN1 patients, unaffected islets stained similar to those in normal samples but with a more peripheral location of positive cells, whereas hyperplastic islets and tumorlets showed increased and diffuse cytoplasmic staining, respectively. Endocrine tumors from MEN1 patients were negative for menin, consistent with a 2-hit loss of a tumor suppressor gene. Secretory granule localization of menin in a subset of islet cells suggests a function of the protein unique to a target organ of familial endocrine neoplasia, although the IHC data must be interpreted with some caution because of the possibility of antibody cross-reaction. The identity, cellular trafficking, and role of this putative secretory granule-form of menin warrant additional investigation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25153502      PMCID: PMC4232475          DOI: 10.1097/PAI.0000000000000046

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  47 in total

1.  c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development.

Authors:  Yuji Nakata; Anne C Brignier; Shenghao Jin; Yuan Shen; Stephen I Rudnick; Mayumi Sugita; Alan M Gewirtz
Journal:  Blood       Date:  2010-05-18       Impact factor: 22.113

Review 2.  A continuum model for tumour suppression.

Authors:  Alice H Berger; Alfred G Knudson; Pier Paolo Pandolfi
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

3.  Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin.

Authors:  S C Huang; Z Zhuang; R J Weil; S Pack; C Wang; H C Krutzsch; T A Pham; I A Lubensky
Journal:  Lab Invest       Date:  1999-03       Impact factor: 5.662

Review 4.  Multiple endocrine neoplasia type 1 (MEN1).

Authors:  Rajesh V Thakker
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

5.  MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.

Authors:  Vincenzo Corbo; Irene Dalai; Maria Scardoni; Stefano Barbi; Stefania Beghelli; Samantha Bersani; Luca Albarello; Claudio Doglioni; Christina Schott; Paola Capelli; Marco Chilosi; Letizia Boninsegna; Karl-Friedrich Becker; Massimo Falconi; Aldo Scarpa
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

6.  Genetic screening for MEN1 mutations in families presenting with familial primary hyperparathyroidism.

Authors:  Nancy D Perrier; Andrea Villablanca; Catharina Larsson; Mariwil Wong; Philip Ituarte; Bin Tean Teh; Orlo H Clark
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

7.  Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin.

Authors:  Yanan Cao; Ruixin Liu; Xiuli Jiang; Jieli Lu; Jingjing Jiang; Changxian Zhang; Xiaoying Li; Guang Ning
Journal:  Mol Cell Biol       Date:  2009-08-03       Impact factor: 4.272

8.  Somatostatin stimulates menin gene expression by inhibiting protein kinase A.

Authors:  Edith Mensah-Osman; Yana Zavros; Juanita L Merchant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-28       Impact factor: 4.052

9.  MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.

Authors:  Gerard V Walls; Manuel C Lemos; Mahsa Javid; Miriam Bazan-Peregrino; Jeshmi Jeyabalan; Anita A C Reed; Brian Harding; Damian J Tyler; Daniel J Stuckey; Sian Piret; Paul T Christie; Olaf Ansorge; Kieran Clarke; Len Seymour; Rajesh V Thakker
Journal:  Cancer Res       Date:  2012-08-21       Impact factor: 12.701

Review 10.  Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

View more
  2 in total

1.  Menin localization in cell membrane compartment.

Authors:  Xin He; Lei Wang; Jizhou Yan; Chaoxing Yuan; Eric S Witze; Xianxin Hua
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

2.  Tumor suppressor menin is required for subunit-specific nAChR α5 transcription and nAChR-dependent presynaptic facilitation in cultured mouse hippocampal neurons.

Authors:  Angela M Getz; Fenglian Xu; Frank Visser; Roger Persson; Naweed I Syed
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.